title: Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial.
authors.affiliation: Medical University Hospital, Goettingen, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Marschner
authors.forename: R
authors.initials: R
authors.lastname: Kreienberg
authors.forename: R
authors.initials: R
authors.lastname: Souchon
authors.forename: U
authors.initials: U
authors.lastname: Räth
authors.forename: B
authors.initials: B
authors.lastname: Eggeling
authors.forename: R
authors.initials: R
authors.lastname: Voigtmann
authors.forename: K
authors.initials: K
authors.lastname: Ruffert
authors.forename: M
authors.initials: M
authors.lastname: Schütte
authors.forename: A
authors.initials: A
authors.lastname: Ammon
authors.forename: T
authors.initials: T
authors.lastname: Kesztyüs
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011446:Prospective Studies; D015996:Survival Rate
chemical_list: D015251:Epirubicin; D003520:Cyclophosphamide